无引流腮腺切除术中使用止血纤维蛋白胶作为辅助剂的初步经验。
Initial experience with hemostatic fibrin glue as adjuvant during drainless parotidectomy.
作者信息
Al-Qahtani Khalid
机构信息
King Saud University, ORL & Head and Neck Surgery, King Abdulaziz Street, Riydah 0533301118, Saudi Arabia.
出版信息
Saudi Dent J. 2011 Apr;23(2):67-71. doi: 10.1016/j.sdentj.2010.11.002. Epub 2010 Nov 27.
OBJECTIVES
To evaluate the use of Hemostatic Fibrin Glue in parotidectomy without the use of surgical drains.
STUDY DESIGN
Prospective cohort study of 10 patients undergoing parotidectomy. Surgery as a one day admission without the use of surgical drains was planned. The complication and duration of the hospital stay were obtained.
METHODS
Parotidectomy was undertaken by one surgeon. Prior to wound closure, the skin flap and wound bed were approximated using Tisseel tissue sealant. Data regarding the incidence of any complication and the duration of the hospital stay were obtained. Patients were followed to assess surgical outcome and document any complications. The mean follow-up period was 8 months (range 4-12 months).
RESULTS
There were no major surgical complications. Two patients had facial nerve weakness due to adherence of the tumour in the facial nerve, in there was which complete recovery after few months. All patients were discharged the next day. None of the patients felt that the discharge had been premature.
CONCLUSIONS
Parotidectomy can be undertaken safely without the need for surgical drains, therefore, allowing the patients to leave the hospital on the first postoperative day.
目的
评估在腮腺切除术中不使用手术引流管而使用止血纤维蛋白胶的情况。
研究设计
对10例行腮腺切除术的患者进行前瞻性队列研究。计划将手术作为一日住院且不使用手术引流管。记录并发症情况及住院时间。
方法
由一名外科医生进行腮腺切除术。在伤口闭合前，使用纤维蛋白封闭剂使皮瓣和创面贴合。获取有关任何并发症发生率及住院时间的数据。对患者进行随访以评估手术效果并记录任何并发症。平均随访期为8个月（范围4 - 12个月）。
结果
无重大手术并发症。2例患者因肿瘤与面神经粘连出现面神经麻痹，数月后完全恢复。所有患者均于次日出院。无一例患者认为出院过早。
结论
腮腺切除术可不使用手术引流管安全进行，从而使患者术后第一天即可出院。
Zotero 插件